Exploring Complex Product Characterization Analysis Session 2b
If you are looking for information about Complex Product Characterization Analysis Session 2b, you have come to the right place.
- Yiwei Li from CDER's Office of Pharmaceutical Quality shares a case study, an introduction to Iron Colloid Drug
- The
- Rachel Dunn, PhD, Director of the Division of Pharmaceutical
- FDA discusses additional topics in
- For more TA webinars, subscribe to our channel or visit our website at: http://www.tainstruments.com This webinar is focused on ...
In-Depth Information on Complex Product Characterization Analysis Session 2b
A presentation and panel discuss new analytical methods that are promising for generic drug development, screening, and ... A presentation and panel discuss potential gaps in A presentation and panel assess analytical methods currently considered most useful and how to better develop these ... Asif Rasheed from the Office of Pharmaceutical Quality discusses common issues and challenges for
Presenters Cameron Smith, Deyi Zhang, and Xiaoming Xu answer audience questions. Learn more at ...
We hope this detailed breakdown of Complex Product Characterization Analysis Session 2b was helpful.
